Giuseppina Russo

5.4k total citations
150 papers, 3.8k citations indexed

About

Giuseppina Russo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Giuseppina Russo has authored 150 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Surgery and 31 papers in Molecular Biology. Recurrent topics in Giuseppina Russo's work include Diabetes Treatment and Management (55 papers), Diabetes Management and Research (25 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Giuseppina Russo is often cited by papers focused on Diabetes Treatment and Management (55 papers), Diabetes Management and Research (25 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Giuseppina Russo collaborates with scholars based in Italy, Spain and United States. Giuseppina Russo's co-authors include Domenico Cucinotta, Salvatore De Cosmo, Francesca Viazzi, Roberto Pontremoli, Carlo Giorda, Annalisa Giandalia, Paola Fioretto, Pietro Guida, Antonio Nicolucci and Antonio Ceriello and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Giuseppina Russo

142 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppina Russo Italy 34 1.6k 704 661 590 487 150 3.8k
Trond Jenssen Norway 37 1.7k 1.0× 904 1.3× 1.4k 2.2× 947 1.6× 591 1.2× 123 4.9k
Qiuhe Ji China 24 2.0k 1.3× 1.0k 1.4× 600 0.9× 281 0.5× 816 1.7× 75 4.2k
Yangang Wang China 30 1.2k 0.7× 1.1k 1.5× 711 1.1× 607 1.0× 463 1.0× 138 3.7k
Sheyu Li China 33 1.6k 1.0× 800 1.1× 836 1.3× 218 0.4× 502 1.0× 133 3.9k
Peter Wahl Switzerland 39 570 0.4× 660 0.9× 1.4k 2.1× 358 0.6× 601 1.2× 145 4.6k
Gaurav Agarwal India 33 1.4k 0.9× 594 0.8× 1.9k 2.8× 851 1.4× 403 0.8× 250 4.9k
Ambrish Mithal India 34 1.1k 0.7× 1.1k 1.5× 931 1.4× 844 1.4× 817 1.7× 114 5.8k
Juming Lu China 24 2.1k 1.3× 1.0k 1.4× 711 1.1× 200 0.3× 774 1.6× 94 4.3k
Chee Fang Sum Singapore 32 1.1k 0.7× 1.5k 2.1× 526 0.8× 438 0.7× 750 1.5× 179 4.6k
Elif I. Ekinci Australia 34 1.7k 1.1× 580 0.8× 709 1.1× 969 1.6× 567 1.2× 207 4.4k

Countries citing papers authored by Giuseppina Russo

Since Specialization
Citations

This map shows the geographic impact of Giuseppina Russo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppina Russo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppina Russo more than expected).

Fields of papers citing papers by Giuseppina Russo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppina Russo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppina Russo. The network helps show where Giuseppina Russo may publish in the future.

Co-authorship network of co-authors of Giuseppina Russo

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppina Russo. A scholar is included among the top collaborators of Giuseppina Russo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppina Russo. Giuseppina Russo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fugazzotto, Paul A., Giuseppe Arena, Carmela Morace, et al.. (2025). Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings. Cells. 14(9). 668–668. 2 indexed citations
3.
Asztalos, Bela F., et al.. (2025). Body Mass Index and Cardiovascular Risk Markers: A Large Population Analysis. Nutrients. 17(5). 740–740. 3 indexed citations
4.
Russo, Giuseppina, Antonio Nicolucci, Valeria Manicardi, et al.. (2025). Type 2 diabetes specialist care in Italy in the AMD Annals initiative 2024: The path is traced. Diabetes Research and Clinical Practice. 225. 112273–112273.
5.
Morace, Carmela, Federica Bellone, Cristina Quartarone, et al.. (2024). Ketoacidosis and SGLT2 Inhibitors: A Narrative Review. Metabolites. 14(5). 264–264. 21 indexed citations
6.
Russo, Giuseppina, Annalisa Giandalia, Maria Chiara Rossi, et al.. (2024). Prevalence and clinical determinants of rapid eGFR decline among patients with newly diagnosed type 2 diabetes. European Journal of Internal Medicine. 130. 123–129. 1 indexed citations
7.
Cucinotta, Domenico, Annalisa Giandalia, & Giuseppina Russo. (2023). After 100 years of life, is there an insulin crisis? The problem of insulin costs and the opportunity of biosimilar insulins. SHILAP Revista de lepidopterología. 11(1). 4–7. 1 indexed citations
8.
Giandalia, Annalisa, Irene Cacciola, Carmela Morace, et al.. (2023). High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine. 12(8). 2858–2858. 6 indexed citations
9.
Ceriello, Antonio, Giuseppe Lucisano, Francesco Prattichizzo, et al.. (2023). The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes. The Lancet Regional Health - Europe. 31. 100666–100666. 21 indexed citations
10.
Russo, Giuseppina, et al.. (2023). The challenging role of micro-RNAs in non-alcoholic fatty liver disease in children with obesity: is it time for a new era?. Expert Review of Gastroenterology & Hepatology. 17(8). 817–824. 1 indexed citations
11.
Leoncini, Giovanna, Francesca Viazzi, Salvatore De Cosmo, et al.. (2020). Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations. Journal of Nephrology. 33(5). 949–963. 45 indexed citations
12.
Leoncini, Giovanna, Salvatore De Cosmo, Giuseppina Russo, et al.. (2019). Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach. SHILAP Revista de lepidopterología. 55(7). 382–382. 6 indexed citations
13.
Russo, Giuseppina, et al.. (2019). GLP-1 Receptor Agonists and Kidney Protection. Medicina. 55(6). 233–233. 109 indexed citations
14.
Musacchio, Nicoletta, A Micheli, A. Giancaterini, et al.. (2019). Diabetologist's core competence curriculum: A position statement of the amd (Italian association of medical diabetologists). Diabetes Management. 9(4). 87–95. 2 indexed citations
15.
Viazzi, Francesca, Giuseppina Russo, Antonio Ceriello, et al.. (2018). Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals. Journal of Nephrology. 32(4). 517–525. 30 indexed citations
16.
Gentile, Sandro, Felice Strollo, Francesca Viazzi, et al.. (2018). Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions. Journal of Diabetes Research. 2018. 1–10. 18 indexed citations
17.
Piscitelli, Pamela, Francesca Viazzi, Paola Fioretto, et al.. (2017). Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative. Scientific Reports. 7(1). 3313–3313. 36 indexed citations
18.
Manicardi, Valeria, Maria Chiara Rossi, Elisabetta L. Romeo, et al.. (2016). Gender differences in type 2 diabetes (Italy). 2(2). 60–68. 3 indexed citations
19.
Russo, Giuseppina, Annalisa Giandalia, Elisabetta L. Romeo, & Domenico Cucinotta. (2015). Gender diff erences in lipoprotein metabolism. 1(2). 58–65. 5 indexed citations
20.
Russo, Giuseppina. (1977). Visceral leishmaniasis: clinical aspects in children.. 29(10). 867–883. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026